English
简体中文
Total: £ 56.28
2026-04-10 | Pages: 134 | Tables: 136
The global Colloidal Nutritional Supplements market was valued at US$ 8812 million in 2025 and is anticipated to reach US$ 13350 million by 2032, at a CAGR of 6.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into th...
2026-04-10 | Pages: 135 | Tables: 132
The global Microemulsion Dietary Supplements market was valued at US$ 3105 million in 2025 and is anticipated to reach US$ 5354 million by 2032, at a CAGR of 8.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the...
2026-04-10 | Pages: 119 | Tables: 118
The global Plant Hard Hollow Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-04-10 | Pages: 110 | Tables: 103
The global Gum Swelling and Pain Relief Medicine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Commonly used anti-inflammatory drugs for treating gum swelling and pain includ...
2026-04-10 | Pages: 117 | Tables: 113
The global IL-8R Inhibitor market was valued at US$ 732 million in 2025 and is anticipated to reach US$ 1250 million by 2032, at a CAGR of 8.1% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic la...
2026-04-10 | Pages: 124 | Tables: 119
The global Acer Truncatum Bunge Seed Oil market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-04-10 | Pages: 122 | Tables: 123
The global IL-8R Agonist market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This r...
2026-04-10 | Pages: 103 | Tables: 102
The global Dry Eye Medication for Dogs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Dry Eye Medication for Dogs is projected to increase from U...
2026-04-10 | Pages: 112 | Tables: 114
The global Umeclidinium Bromide market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
2026-04-10 | Pages: 117 | Tables: 108
The global Revefenacin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This rep...
2026-04-10 | Pages: 117 | Tables: 111
The global Rivastigmine Hydrogen Tartrate API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-04-10 | Pages: 110 | Tables: 110
The global Rivastigmine API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. Thi...
2026-04-10 | Pages: 108 | Tables: 114
The global Rivastigmine Patch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. T...
2026-04-10 | Pages: 137 | Tables: 140
The global Emphysema Treatment Medication market was valued at US$ 4392 million in 2025 and is anticipated to reach US$ 5488 million by 2032, at a CAGR of 3.3% from 2026 to 2032.Emphysema is a chronic and progressive lung condition characterized by d...
2026-04-10 | Pages: 117 | Tables: 117
The global Calcobutrol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This rep...
